Nonprofit Funds Essential for Researchers
Imatinib Can Reverse Fibrosis in Models of SSc
New Site Helps Researchers Find Non-federal Funds
Caregiving Youth
Bad Breath and Halitosis Cause and Remedy
Cold Hands?
We Need Your Help
February 28 Is Rare Disease Day
Photo of the Week
Spring Swing Deadline to Enter: March 15
Stepping Out Walks
Commemorative Stamp for Scleroderma
 |
February 28 Is Rare Disease Day!
To raise awareness of rare diseases and the need for safe, effective treatments, people around the world will join together to observe the 2nd Annual Rare Disease Day on the last day of February (Feb. 28, 2009). |
Photo of the Week
The Scleroderma Foundation extends its congratulations to Lucy Leonard (left) of Lake Havasu City, Arizona. Lucy recently received Special Recognition (physical limitation) and the People's Choice award at the Northern Arizona V.A. Health Care System Veterans Creative Arts Festival this past February. |
|
DEADLINE TO ENTER: MARCH 15
Register today for the Spring Swing Women's Doubles Tennis Tournament at the fabulous, AAA Four Diamond PGA National Resort & Spa in Palm Beach Gardens, Florida, March 21.
More... |
Stepping Out to Cure Scleroderma Walks Gearing Up
Find a walk near you! |
Commemorative Stamp for Scleroderma
The Scleroderma Foundation
is pursuing a commemorative stamp for scleroderma.
We
need your help! |
|
|
 |
|
|
 |
Maureen Mayes, M.D. is a member of the Scleroderma Foundation's Medical Advisory Board |
By Maureen Mayes, M.D.
As I hear about charitable institutions losing funding this year due to the economic climate, I think back to 1983 when I received my first research grant.
That grant ultimately decided my career path, my research interest and perhaps, if my colleagues and I are correct in our hypotheses, the course of treatment of an incurable disease.
I received my first grant as a young medical doctor deciding between academic medicine and private practice from the Scleroderma Foundation to study scleroderma, a rare, incurable autoimmune disease. |
|
|
 NEW YORK (Reuters Health) –- Imatinib mesylate (Gleevec/Glivec) not only prevents the development of fibrosis in systemic sclerosis but actually reverses established fibrosis in an animal model of the disease.
You will need a login and password to Medscape.com in order to read this article. You can get them free here. |
|
 |
Julie Koh, Ph.D., Director of Development for Biomedical Research |
Thanks to “FIND Grants,” a new Web site that helps Vanderbilt Medical Center faculty, clinicians, and scientists find sources of non-federal funding, the days of inefficient Google searches are over.
FIND Grants, short for Foundation INitiatives Database, allows researchers to hone search criteria by factors such as experience level, citizenship, award amount and deadline to find the funding opportunities for which they are best suited. |
|
|
The face of caregivers in the United States today represents every race, ethnicity and religious sect. They can be found in virtually every zip code. And yet, there is still a population of caregivers that often remains invisible. It is estimated that 1.4 million children in the United States participate in the care of a family member or loved one who is either critically or chronically ill. Either living in the same home or nearby the ailing person, these children partake in a wide variety of activities of daily living including everything from bathing to shopping. |
|
|
 Categories include:
- bad breath causes
- bad breath cures
- bad breath remedies
- bad breath remedy
- bad breath treatment
|
|
|
Don't blame it on the weather: How icy fingers could be a sign of something more serious...
Cold hands are not only a sign that the weather's bitter—they could be a symptom of something more serious.
There are at least a dozen conditions which cause chronic cold hands, including peripheral vascular disease and ME. |
|
WE NEED YOUR HELP
How Do You Generate Awareness for Scleroderma?
The Scleroderma Foundation is asking community members nationwide to share their own creative and unique ways of generating awareness for scleroderma. All responses received will be reviewed by the Foundation’s staff and eligible for inclusion in the upcoming June issue of the "Scleroderma Voice" magazine. Interested individuals may submit their responses (100 words or less) via e-mail at shall@scleroderma.org or by mail: Communications Department, c/o Scleroderma Foundation, 300 Rosewood Drive Suite 105, Danvers, MA 01923. Please be sure to include your contact information with your response. All responses must be received by March 31, 2009 to be eligible for publication. |
|
